Stock 002653 HAISCO PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Haisco Pharmaceutical Group Co., Ltd.

Equities

002653

CNE100001BC7

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
28.49 CNY +1.03% Intraday chart for Haisco Pharmaceutical Group Co., Ltd. +9.96% +23.07%
Apr. 19 Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 18 Haisco Pharmaceutical Gets Nod to Trial HSK16149 Capsules MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 21,777 18,638 21,747 23,695 25,545 31,438 - -
Enterprise Value (EV) 1 21,777 18,638 21,747 23,695 25,545 31,438 31,438 31,438
P/E ratio 43.3 x 30.2 x 63.8 x 85.6 x 85.7 x 57 x 50.4 x 23 x
Yield - - - - 0.86% 0.42% 0.53% -
Capitalization / Revenue 5.53 x 5.59 x 7.84 x - 7.61 x 8.11 x 6.16 x 4.69 x
EV / Revenue 5.53 x 5.59 x 7.84 x - 7.61 x 8.11 x 6.16 x 4.69 x
EV / EBITDA - 23.1 x 31.4 x - 48.3 x 45 x 28.8 x 19.5 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book - 6.46 x 7.73 x - 6.17 x 6.67 x 6.43 x 4.52 x
Nbr of stocks (in thousands) 1,069,612 1,063,821 1,066,028 1,064,949 1,103,460 1,103,460 - -
Reference price 2 20.36 17.52 20.40 22.25 23.15 28.49 28.49 28.49
Announcement Date 2/28/20 2/26/21 4/26/22 4/17/23 4/19/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,938 3,337 2,773 - 3,355 3,876 5,104 6,709
EBITDA 1 - 805.9 691.9 - 529.1 699 1,093 1,616
EBIT 1 - 692.2 512.3 - 313.5 600 996 1,532
Operating Margin - 20.74% 18.47% - 9.35% 15.48% 19.52% 22.83%
Earnings before Tax (EBT) 1 - 688 510.7 - 302.5 600 996 1,532
Net income 1 - 618.4 345.1 277 295.1 552 633 1,379
Net margin - 18.53% 12.44% - 8.8% 14.24% 12.4% 20.55%
EPS 2 0.4700 0.5800 0.3200 0.2600 0.2700 0.5000 0.5650 1.240
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - 0.2000 0.1200 0.1500 -
Announcement Date 2/28/20 2/26/21 4/26/22 4/17/23 4/19/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 971.1 752.1 954 1,182 1,279
EBITDA - - - - -
EBIT - - - - -
Operating Margin - - - - -
Earnings before Tax (EBT) - - - - -
Net income - - - - -
Net margin - - - - -
EPS 2 0.0900 0.0800 0.0600 0.0800 0.0600
Dividend per Share - - - - -
Announcement Date 4/19/24 4/19/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) - 23.4% 12.3% - 9.19% 11.6% 12.6% 19.6%
ROA (Net income/ Total Assets) - - - - - 7.9% 7.9% 14.6%
Assets 1 - - - - - 6,987 8,013 9,445
Book Value Per Share 2 - 2.710 2.640 - 3.750 4.270 4.430 6.310
Cash Flow per Share 2 - 0.1900 0.0300 - 0.4000 0.4000 0.4600 0.9700
Capex 1 - 600 703 - 387 66 - -
Capex / Sales - 17.98% 25.33% - 11.53% 1.7% - -
Announcement Date 2/28/20 2/26/21 4/26/22 4/17/23 4/19/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Haisco Pharmaceutical Group Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
28.49
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
HAISCO PHARMACEUTICAL GROUP CO., LTD. Stock Haisco Pharmaceutical Group Co., Ltd.
+23.07% 4.34B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002653 Stock
  4. Financials Haisco Pharmaceutical Group Co., Ltd.